Whole-Exome Sequencing Identified a Novel Mutation in RNF216 in a Family with Gordon Holmes Syndrome

J Mol Neurosci. 2022 Apr;72(4):691-694. doi: 10.1007/s12031-021-01953-0. Epub 2022 Jan 28.

Abstract

Gordon Holmes syndrome (GHS) is a rare disease characterized by hypogonadotropic hypogonadism (HH), progressive cognitive decline and variable movement disorders. Mutations in RNF216 have been found to be associated with GHS. Here, we identify a novel homozygous RNF216 p.E650X mutation causing GHS. The proband presented with onset dysarthria and developed cerebellar ataxia and cognitive impairment, with a history of azoospermia at the age of 28 years. Cerebellar atrophy and white matter lesions were found in the cerebral hemispheres and brainstem. Low gonadotropin serum levels were also observed. Whole-exome sequencing (WES) revealed a novel homozygous nonsense variant in RNF216, c.1948G>T; p.E650X. Our finding furthers the genetic knowledge of GHS and extends the ethnic distribution of RNF216 mutations.

Keywords: Cerebellar ataxia; Hypogonadotropic hypogonadism; RNF216; Whole-exome sequencing.

MeSH terms

  • Adult
  • Cerebellar Ataxia* / genetics
  • Exome Sequencing
  • Gonadotropin-Releasing Hormone / deficiency
  • Humans
  • Hypogonadism* / genetics
  • Mutation
  • Pedigree
  • Ubiquitin-Protein Ligases / genetics

Substances

  • Gonadotropin-Releasing Hormone
  • RNF216 protein, human
  • Ubiquitin-Protein Ligases

Supplementary concepts

  • Cerebellar Ataxia and Hypogonadotropic Hypogonadism